HIGHOutside partySupplier
sole suppliers for certain components, raw materials and services
“10-K Item 1A: 'certain components, raw materials and services needed to manufacture our products are obtained from sole suppliers'”
MDT · Concentration risk · 10-K extracted
Medtronic (MDT) concentration risks
Updated
The most significant concentration Medtronic discloses is sole suppliers for certain components, raw materials and services, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Medtronic’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 1 disclosed concentration
HIGH1
MEDIUM0
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-08-23Medtronic's disclosed concentration risk is narrow in scope but consequential in kind: a single high-share, dependency-type exposure. The company states that certain components, raw materials and services needed to manufacture its products are obtained from sole suppliers, meaning for these inputs there is no readily available alternate source. This is a counterparty-specific risk rather than a market-wide one — it sits with individual suppliers rather than being tied to macro conditions like currency or regional demand. For a global medical device manufacturer of Medtronic's scale, sole-sourcing even a subset of components creates a single point of failure: a disruption, quality issue, or commercial dispute with any one of these suppliers could interrupt manufacturing for the affected product lines until an alternate source is qualified — a process that in regulated medical device manufacturing can take time. No customer, geographic, or revenue-line concentration is disclosed in the reviewed filing excerpt, so the visible risk here is confined to procurement rather than the demand side of the business. Investors should treat this as a monitorable, idiosyncratic operational risk rather than a broad-based earnings concentration.
For the engine’s reasoning on MDT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| MDT● | Medtronic plc. | 1 | 0 | 0 | 1 |
| AHCO | AdaptHealth Corp. | 0 | 0 | 0 | 0 |
| AXGN | AxoGen, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.